Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Photys Therapeutics

Request full access

A proprietary chimeric small molecules platform company, developing a new class of medicines for precise control of protein function

Waltham, United StatesFounded 2021Biotech & Life Sciences

About Photys Therapeutics

Photys Therapeutics is a biotech startup that operates in the pharmaceutical industry, focusing on the development of bifunctional small molecules. These molecules are designed to control protein post-translational modifications, a process that can restore protein function, repair signaling, and amplify the body's natural disease-fighting mechanisms. This innovative approach goes beyond traditional degradation methods, offering a new way to tackle diseases at a molecular level.

The company was co-founded by Amit Choudhary, a leading bifunctional chemist from the Broad Institute, and the Longwood Fund. It also boasts a scientific advisory board composed of esteemed scientists and drug developers from institutions such as MIT, Salk, Berkeley, MPM, and Dana Farber.

Photys Therapeutics' primary product is Phosphorylation-Inducing Chimeric Small Molecules (PHICS). These molecules are designed to precisely modulate and repair disease-driving proteins, offering a potential breakthrough in the treatment of various diseases.

The company recently secured $75 million in Series A funding, indicating strong investor confidence in its business model and scientific approach. This funding will be used to advance the development and testing of its bifunctional molecules.

Photys Therapeutics operates on a business model common in the biotech industry. It invests in research and development to create innovative pharmaceutical products. Once these products are approved for use, the company generates revenue by selling them to healthcare providers and patients.

Source: Dealroom company data

At a glance

Status
Operational
Employees
10
Open positions
1
Dealroom signal
60.4/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Sep 2022 $75M $300M Merck & Co. · 8VC · Eli Lilly · Mass General Brigham Ventures ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Photys Therapeutics website traffic

Latest recorded traffic for Photys Therapeutics is 960 monthly website visits, down 61.6% over the last three months. Photys Therapeutics's team declined 44.4% over the past year.

Latest monthly visits960 3-month web change-61.6% 1-year team growth-44.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Photys Therapeutics in the Waltham ecosystem

Live from Dealroom

The Photys Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A10 investors entered at this stage

  • MPM BioImpact
  • Merck & Co.
  • 8VC
  • Eli Lilly
  • Mass General Brigham Ventures
  • Longwood Fund
  • Arkin Capital
  • Omega Funds
  • MRL Ventures
  • Heritage Medical Systems
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Photys Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Photys Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.